Minimum 1 box
The Rapid COVID-19 Innova Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nose and/or throat swab from individuals who are suspected of COVID-19 by their healthcare provider.
Deliveries will be done in 72 hours.
For business/wholesale enquiries please email us at info@h4healthcare.co.uk
Postage Charges will be £5.00 on each case and above £10,000 Free delivery.
The post Innova IVD Covid Testing Kits appeared first on H4 HealthCare.
]]>- Easy to Use: It is easy to use because special equipment needed and intuitive visual interpretation.
- Rapid: Quick sampling with results in 15 min.
- Convenient: All necessary reagents provide and because of this no other equipment needed.
- German Registration: Registered with the German equivalent of the MHRA – the Federal Institue for Drugs and Medical Devices.
- EU Manufactured: Manufactured and evaluated in Germany by MöLab.
- CE Marked: For professional use.
- Accurate: >99.9% Specificity, 97.3% Sensitivity and 99.0% Accuracy.
- ISO13485: Healgen manufacture in accordance with their ISO13485 Quality Management accreditation. They are held many additional ISO accreditations.
This antigen test is intended for use by clinical professionals.
The Rapid Innova IVD Covid Testing Kits. The test is an in vitro lateral flow. The test assay for the qualitative. Detection of nucleocapsid protein antigen from SARS-CoV-2 indirect nose. The throat swab from individuals. Who is suspected of COVID-19 by their healthcare provider?
It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. Currently, the individuals infected by SARS-CoV-2 are the main source of transmission. Asymptomatic carriers are called sources of transmission. Based on the current epidemiological information. Symptoms include fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache. New loss of taste or smell, sore throat, runny nose, nausea or vomiting, and diarrhea.
These rapid lateral flow tests generate accurate results, usually within 15 minutes. This Antigen test has 100% specificity, 98.98% overall accuracy.
- Qualitative, visually read results in 15 minutes.
- No instrument require.
- Room temperature storage or refrigerate.
- Procedural internal control include.
- Sterile Swabs, Extraction Buffer, and Extraction Tubes include.
- Dispose of used test components according to the IFU.
Box Content:
Each box contains everything to perform 25 tests, and comprises of:
- Test device – individual foil wrapped with desiccant x 25 cassettes.
- Extraction buffer solution x 2 bottles.
- Sterile swabs x 25.
- Extraction tubes x 25.
- Instructions for use and Quick Reference Guide.
Test Procedure:
- Specimen Collection (Nasal Swab Collection).
- Specimen Collection (Throat Swab Collection).
- Sample preparation.
- Interpretation of Results.
Test results:
- POSITIVE – The presence of two lines as control line (C) and test line (T) within the result window indicates a positive result.
- NEGATIVE – The presence of only control line (C) within the result window indicates a negative result.
- INVALID – If the control line (C) is not visible within the result window after performing the test. The result is consider invalid. It is recommend that the specimen be re-test using a new test.
Note:
The intensity of color in the test line region (T) may vary depending on the concentration of analytes present in the specimen. Insufficient specimen volume, incorrect operating procedure, or expired tests are the most likely reasons for control band failure.
The Government is report considering buying 200 million of the “lateral flow” tests, of which 60 million would be available in January.
Leaked documents seen by the Daily Telegraph. Suggest that a deal would be sign next month to acquire 192 million lateral flow tests, which cost about £5 each, by next March.
This would pave the way for people who tested negative in the morning to be allow to attend football matches, theatres, and pubs.
Official sources said the figures were “indicative only and may be subject to change” but confirm plans for a “massive increase” in testing capacity — the so-call Moonshot strategy.
London boroughs that were left off an initial government list of priority areas said this had been an “oversight” and that tests would now be made available.
But it came as experts today cast doubt on the accuracy of the tests, warning that between one in four and one in two asymptomatic people with covid may not have the virus detect.
The Government claims the Innova antigen test that is being used in the two-week mass screening pilot in Liverpool detects 76.8 percent of cases of covid — and up to 95 percent in people who have a higher “viral load” and thus are more likely to be infectious.
For more
Health care
Related Products
The post Innova IVD Covid Testing Kits appeared first on H4 HealthCare.
]]>